These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7885985)

  • 1. [Excretion of beta-2-microglobulin and Tamm-Horsfall protein in patients undergoing a conditioning regimen before bone marrow transplantation].
    Franek E; Kokot F; Wojnar J; Wacławik A; Duława J; Wiecek A; Markiewicz M; Hołowiecki J
    Pol Arch Med Wewn; 1994 Nov; 92(5):381-6. PubMed ID: 7885985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Concentrations of B2-microglobulin and Tamm-Horsfall protein in cyst fluid and urinary excretion of these proteins in patients with simple renal cysts].
    Franek E; Bar A; Kokot F; Duława J; Wiecek A; Kochańska-Dziurowicz A; Bar K; Szkodny A; Pawłowski W; Myrta J
    Pol Arch Med Wewn; 1994 Aug; 92(2):107-15. PubMed ID: 7800578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute renal toxicity of 2 conditioning regimens in patients undergoing autologous peripheral blood stem-cell transplantation. Total body irradiation-cyclophosphamide versus ifosfamide, carboplatin, etoposide.
    Beyzadeoglu M; Arpaci F; Surenkok S; Ozyigit G; Oysul K; Caglar K; Ataergin S; Yenicesu M; Kaya A
    Saudi Med J; 2008 Jun; 29(6):832-6. PubMed ID: 18521460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of determination of urinary albumin, beta 2 microglobulin and Tamm-Horsfall protein in diabetics].
    Yu M; Zhu YQ
    Zhonghua Nei Ke Za Zhi; 1991 Jun; 30(6):354-6, 383. PubMed ID: 1914672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of altering administration order of busulphan and cyclophosphamide on the myeloablative and immunosuppressive properties of the conditioning regimen in mice.
    Nilsson C; Forsman J; Hassan Z; Abedi-Valugerdi M; O'Connor C; Concha H; Jansson M; Hassan M
    Exp Hematol; 2005 Mar; 33(3):380-7. PubMed ID: 15730862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The activity of renal glomeruli and tubules during uncomplicated pregnancy: influence of delivery on urinary excretion of albumin, beta 2-microglobulin and Tamm-Horsfall protein].
    Bockenek S; Duława J; Kokot F; Kokot M; Bar A
    Ginekol Pol; 1997 May; 68(5A):226-31. PubMed ID: 9480237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of epidermal growth factor and Tamm-Horsfall protein in three rat models with increased renal excretion of urine.
    Thulesen J; Jørgensen PE; Torffvit O; Nexø E; Poulsen SS
    Regul Pept; 1997 Oct; 72(2-3):179-86. PubMed ID: 9652978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of Tamm-Horsfall protein and epidermal growth factor in chronic nephropathy.
    Torffvit O; Jørgensen PE; Kamper AL; Holstein-Rathlou NH; Leyssac PP; Poulsen SS; Strandgaard S
    Nephron; 1998; 79(2):167-72. PubMed ID: 9647496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase I study of gemtuzumab ozogamicin (GO) in combination with busulfan and cyclophosphamide (Bu/Cy) and allogeneic stem cell transplantation in children with poor-risk CD33+ AML: a new targeted immunochemotherapy myeloablative conditioning (MAC) regimen.
    Satwani P; Bhatia M; Garvin JH; George D; Dela Cruz F; Le Gall J; Jin Z; Schwartz J; Duffy D; van de Ven C; Foley S; Hawks R; Morris E; Baxter-Lowe LA; Cairo MS
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):324-9. PubMed ID: 22079471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
    Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
    Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimens.
    Liu QF; Fan ZP; Wu MQ; Sun J; Wu XL; Xu D; Jiang QL; Zhang Y; Huang F; Wei YQ; Zhao J; Yu GP; Meng FY
    Ann Hematol; 2013 May; 92(5):679-87. PubMed ID: 23274355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
    Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
    Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of etoposide, cyclophosphamide, and total body irradiation in allogeneic bone marrow transplantation for adult patients with hematological malignancies.
    Toubai T; Tanaka J; Mori A; Hashino S; Kobayashi S; Ota S; Miura Y; Kato N; Kahata K; Izumiyama K; Yonezumi M; Chiba K; Kondo T; Toyoshima N; Asaka M; Imamura M
    Clin Transplant; 2004 Oct; 18(5):552-7. PubMed ID: 15344959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.
    Ballester OF; Agaliotis DP; Hiemenz JW; Janssen WE; Fields KK; Zorksy PE; Goldstein SC; Perkins JB; Elfenbein GJ
    Bone Marrow Transplant; 1996 Jul; 18(1):9-14. PubMed ID: 8831989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning.
    Raiola AM; Dominietto A; Ghiso A; Di Grazia C; Lamparelli T; Gualandi F; Bregante S; Van Lint MT; Geroldi S; Luchetti S; Ballerini F; Miglino M; Varaldo R; Bacigalupo A
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):117-22. PubMed ID: 22940057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation.
    Emminger W; Emminger-Schmidmeier W; Haas OA; Urban C; Ambros P; Peters C; Mann G; Fink FM; Ferstl G; Höcker P
    Bone Marrow Transplant; 1992 May; 9(5):313-8. PubMed ID: 1617314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary excretion of Tamm-Horsfall protein, albumin and beta-2 microglobulin in children with recurrent urinary tract infection].
    Wolska-Duda I; Duława J; Kokot F
    Pol Merkur Lekarski; 2001 Jul; 11(61):36-9. PubMed ID: 11579828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of new flu-bu12-tg conditioning with the standard bu-cy myeloablative regimen in patients undergoing allogeneic stem cell transplantation for acute myeloid leukemia.
    Raida L; Tucek P; Faber E; Vondrakova J; Rusinakova Z; Skoumalova I; Hubacek J; Jarosova M; Katrincsakova B; Pikalova Z; Kurfurst P; Indrak K
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Dec; 155(4):327-32. PubMed ID: 22336644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma.
    Bensinger WI; Buckner CD; Clift RA; Petersen FB; Bianco JA; Singer JW; Appelbaum FR; Dalton W; Beatty P; Fefer A
    J Clin Oncol; 1992 Sep; 10(9):1492-7. PubMed ID: 1517792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extramedullary toxicity of a conditioning regimen containing busulphan, cyclophosphamide and etoposide in 84 patients undergoing autologous and allogenic bone marrow transplantation.
    Crilley P; Topolsky D; Styler MJ; Bernstein E; Resnick K; Mullaney R; Bulova S; Brodsky I; Marks DI
    Bone Marrow Transplant; 1995 Mar; 15(3):361-5. PubMed ID: 7599559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.